Margetuximab (Anti-ERBB2 / HER2 / CD340) | HER2 | Read Reviews & Product Use Citations

Margetuximab (Anti-ERBB2 / HER2 / CD340) is a Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. MW: 146.1 KD.

Purity & Quality Control

Batch: A289901 Purity: 99% Protein concentration: 7.96mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective HER2 Inhibitors

Biological Activity

Description	Margetuximab (Anti-ERBB2 / HER2 / CD340) is a Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. MW: 146.1 KD.

References
[1] Nordstrom JL, et al. Breast Cancer Res. 2011;13(6):R123.

References

[1] Nordstrom JL, et al. Breast Cancer Res. 2011;13(6):R123.

Product Details

CAS No.	1350624-75-7
Molecular Weight	146.1
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field